Molecular docking analysis of 6-paradol, Zingerone and Zerumbone against human estrogen receptor alpha (ERɑ)

Molecular docking was done to assess the binding affinity of 6-paradol (6PRD), Zingerone (ZGR) and Zerumbone (ZRB) ligand-ERα complex in comparison to Hydroxytamoxifen (HTMX). Docking results showed that Glu353 and Arg394 active residues forms hydrogen bonding with 6PRD and ZGR. Glu353, Leu387 and...

Full description

Bibliographic Details
Main Authors: Sharif, Mohd. Faez, Azirudin, Athirah, Saedudin, RD Rohmat, Mohd Yunus, Afdzal, Abdul Hamid, Azzmer Azzar, Kasim, Shahreen
Format: Article
Language:English
English
English
Published: Penerbit UTHM 2018
Subjects:
Online Access:http://irep.iium.edu.my/68125/
http://irep.iium.edu.my/68125/
http://irep.iium.edu.my/68125/
http://irep.iium.edu.my/68125/1/68125_Molecular%20docking%20analysis%20of%206-paradol.pdf
http://irep.iium.edu.my/68125/2/68125_Molecular%20docking%20analysis%20of%206-paradol_SCOPUS.pdf
http://irep.iium.edu.my/68125/3/68125_Molecular%20docking%20analysis%20of%206-paradol_WOS.pdf
id iium-68125
recordtype eprints
spelling iium-681252019-01-25T03:48:21Z http://irep.iium.edu.my/68125/ Molecular docking analysis of 6-paradol, Zingerone and Zerumbone against human estrogen receptor alpha (ERɑ) Sharif, Mohd. Faez Azirudin, Athirah Saedudin, RD Rohmat Mohd Yunus, Afdzal Abdul Hamid, Azzmer Azzar Kasim, Shahreen Q Science (General) Molecular docking was done to assess the binding affinity of 6-paradol (6PRD), Zingerone (ZGR) and Zerumbone (ZRB) ligand-ERα complex in comparison to Hydroxytamoxifen (HTMX). Docking results showed that Glu353 and Arg394 active residues forms hydrogen bonding with 6PRD and ZGR. Glu353, Leu387 and Arg394 were the three identical residues found to formed hydrophobic interaction in HTMX-ERα, 6PRD-ERα and ZGR-ERα. HTMX showed lowest binding energy (-10.71 ± 0.43 kcal/mol) followed by ZRB (-8.66 ± 0.04 kcal/mol), 6PRD (-6.92 ± 0.14 kcal/mol) and ZGR (-5.93 ± 0.31 kcal/mol). Inhibition constant (Ki) range of 6PRD-ERα was found to be drastically lower than HTMX-ERα, ZGR-ERα and ZRB-ERα. Based on the docking analysis, the three bioactive compounds were showed to poses low potential as substitute towards tamoxifen. Future study is recommended for analysing 6PRD potential in substituting estradiol as Hormone Replacement Therapy (HRT) for breast cancer. Penerbit UTHM 2018 Article PeerReviewed application/pdf en http://irep.iium.edu.my/68125/1/68125_Molecular%20docking%20analysis%20of%206-paradol.pdf application/pdf en http://irep.iium.edu.my/68125/2/68125_Molecular%20docking%20analysis%20of%206-paradol_SCOPUS.pdf application/pdf en http://irep.iium.edu.my/68125/3/68125_Molecular%20docking%20analysis%20of%206-paradol_WOS.pdf Sharif, Mohd. Faez and Azirudin, Athirah and Saedudin, RD Rohmat and Mohd Yunus, Afdzal and Abdul Hamid, Azzmer Azzar and Kasim, Shahreen (2018) Molecular docking analysis of 6-paradol, Zingerone and Zerumbone against human estrogen receptor alpha (ERɑ). International Journal of Integrated Engineering, 10 (6 Special Issue 2018: Data Information Engineering). pp. 113-118. ISSN 2229-838X E-ISSN 2600-7916 http://penerbit.uthm.edu.my/ojs/index.php/ijie/article/view/2770/1769 10.30880/ijie.2018.10.06.015
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
English
English
topic Q Science (General)
spellingShingle Q Science (General)
Sharif, Mohd. Faez
Azirudin, Athirah
Saedudin, RD Rohmat
Mohd Yunus, Afdzal
Abdul Hamid, Azzmer Azzar
Kasim, Shahreen
Molecular docking analysis of 6-paradol, Zingerone and Zerumbone against human estrogen receptor alpha (ERɑ)
description Molecular docking was done to assess the binding affinity of 6-paradol (6PRD), Zingerone (ZGR) and Zerumbone (ZRB) ligand-ERα complex in comparison to Hydroxytamoxifen (HTMX). Docking results showed that Glu353 and Arg394 active residues forms hydrogen bonding with 6PRD and ZGR. Glu353, Leu387 and Arg394 were the three identical residues found to formed hydrophobic interaction in HTMX-ERα, 6PRD-ERα and ZGR-ERα. HTMX showed lowest binding energy (-10.71 ± 0.43 kcal/mol) followed by ZRB (-8.66 ± 0.04 kcal/mol), 6PRD (-6.92 ± 0.14 kcal/mol) and ZGR (-5.93 ± 0.31 kcal/mol). Inhibition constant (Ki) range of 6PRD-ERα was found to be drastically lower than HTMX-ERα, ZGR-ERα and ZRB-ERα. Based on the docking analysis, the three bioactive compounds were showed to poses low potential as substitute towards tamoxifen. Future study is recommended for analysing 6PRD potential in substituting estradiol as Hormone Replacement Therapy (HRT) for breast cancer.
format Article
author Sharif, Mohd. Faez
Azirudin, Athirah
Saedudin, RD Rohmat
Mohd Yunus, Afdzal
Abdul Hamid, Azzmer Azzar
Kasim, Shahreen
author_facet Sharif, Mohd. Faez
Azirudin, Athirah
Saedudin, RD Rohmat
Mohd Yunus, Afdzal
Abdul Hamid, Azzmer Azzar
Kasim, Shahreen
author_sort Sharif, Mohd. Faez
title Molecular docking analysis of 6-paradol, Zingerone and Zerumbone against human estrogen receptor alpha (ERɑ)
title_short Molecular docking analysis of 6-paradol, Zingerone and Zerumbone against human estrogen receptor alpha (ERɑ)
title_full Molecular docking analysis of 6-paradol, Zingerone and Zerumbone against human estrogen receptor alpha (ERɑ)
title_fullStr Molecular docking analysis of 6-paradol, Zingerone and Zerumbone against human estrogen receptor alpha (ERɑ)
title_full_unstemmed Molecular docking analysis of 6-paradol, Zingerone and Zerumbone against human estrogen receptor alpha (ERɑ)
title_sort molecular docking analysis of 6-paradol, zingerone and zerumbone against human estrogen receptor alpha (erɑ)
publisher Penerbit UTHM
publishDate 2018
url http://irep.iium.edu.my/68125/
http://irep.iium.edu.my/68125/
http://irep.iium.edu.my/68125/
http://irep.iium.edu.my/68125/1/68125_Molecular%20docking%20analysis%20of%206-paradol.pdf
http://irep.iium.edu.my/68125/2/68125_Molecular%20docking%20analysis%20of%206-paradol_SCOPUS.pdf
http://irep.iium.edu.my/68125/3/68125_Molecular%20docking%20analysis%20of%206-paradol_WOS.pdf
first_indexed 2023-09-18T21:36:41Z
last_indexed 2023-09-18T21:36:41Z
_version_ 1777412868027711488